Linear IgA dermatosis with IgA and IgG autoantibodies to the 180 kDa bullous pemphigoid antigen (BP180): Evidence for a distinct subtype

International Journal of Dermatology

Volumn 43, Issue 6, 2004, Pages 443-446

  Metz, Brandie J ^a,b   Ruggeri, Sun Young ^a,b   Hsu, Sylvia ^a,b   Reed, Jon A ^a,b   Ghohestani, Ali S ^a,b   Uitto, Jouni ^a,b   Ghohestani, Reza F ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; AUTOANTIBODY; COLLAGEN TYPE 4; DAPSONE; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN SUBCLASS; KALININ; MEMBRANE PROTEIN; PREDNISONE; PROTEIN HYDROLYSATE; PROTEIN SUBUNIT;

ADULT; ANTIGEN ANTIBODY REACTION; ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNE DISEASE; BULLOUS SKIN DISEASE; CASE REPORT; DERMOEPIDERMAL JUNCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL CULTURE; IMMUNOFLUORESCENCE TEST; IMMUNOGLOBULIN DEPOSITION; INFLAMMATORY INFILTRATE; KERATINOCYTE; LINEAR IMMUNOGLOBULIN A DERMATOSIS; PATHOPHYSIOLOGY; PEMPHIGOID; WESTERN BLOTTING;

ADULT; AUTOANTIBODIES; AUTOANTIGENS; AUTOIMMUNE DISEASES; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; PEMPHIGOID, BULLOUS;

EID: 3042803649     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2004.02016.x     Document Type: Article

References (21)

1. Zone J. Clinical spectrum, pathogenesis and treatment of linear IgA bullous dermatosis. J Dermatol 2001; 28: 651-653.
2. Guide SV, Marinkovich MP. Linear IgA bullous dermatosis. Clin Dermatol 2001; 19: 719-727.
3. Zone JJ, Taylor TB, Meyer LJ, et al. The 97 kDa linear IgA bullous disease antigen is identical to a portion of the extracellular domain of the 180 kDa bullous pemphigoid antigen, BPAg2. J Invest Dermatol 1998; 110: 207-210.
4. Peyron E, Nicolas JF, Reano A, et al. Human monoclonal autoantibodies specific for the bullous pemphigoid antigen 1 (BPAg 1). J Immunol 1994; 1153: 1333-1339.
5. Ghohestani RF, Cozzani E, Delaporte E, et al. IgE antibodies in sera from patients with bullous pemphigoid are autoantibodies preferentially directed against the 230-kDa epidermal antigen (BP230). J Clin Immunol 1988; 18: 202-209.
6. Ghohestani RF, Kanitakis J, Nicolas JF, et al. Comparative sensitivity of indirect immunofluorescence to immunoblot assay for the detection of circulating antibodies to bullous pemphigoid antigens 1 and 2. Br J Dermatol 1996; 135: 74-79.
7. Ghohestani RF, Hudson BG, Claudy A, et al. The alpha 5 chain of type IV collagen is the target of IgG autoantibodies in a novel autoimmune disease with subepidermal blisters and renal insufficiency. J Biol Chem 2000; 275: 16,002-16,006.
8. Ghohestani RF, Nicolas JF, Rousselle P, et al. Diagnostic value of indirect immunofluorescence on sodium chloride-split skin in differential diagnosis of subepidermal autoimmune bullous dermatoses. Arch Dermatol 1977; 133: 1102-1107.
9. Ghohestani RF, Nicolas JF, Kanitakis J, et al. Linear IgA bullous dermatosis with IgA antibodies exclusively directed against the 180- or 230-kDa epidermal antigens. J Invest Dermatol 1997; 108: 854-858.
10. Zone JJ, Pazderka S, Pwell D, et al. Antigenic specificity of antibodies from patients with linear basement membrane deposition of IgA. Dermatology 1994; 189: 64-66.
11. Kromminga A, Scheckenbach C, Georgi M, et al. Patients with bullous pemphigoid and linear IgA disease show a dual IgA and IgG autoimmune response to BP180. J Autoimmun 2000; 15: 293-300.
12. Setterfield J, Shirlaw PJ, Kerr-Muirr M, et al. Mucous membrane pemphigoid: a dual circulating antibody response with IgG and IgA signifies a more severe and persistent disease. Br J Dermatol 1998; 1138: 602-610.
13. Zambruno G, Manca V, Kanitakas J, et al. Linear IgA bullous dermatosis with autoantibodies to a 290 kd antigen of anchoring fibrils. J Am Acad Dermatol 1994; 31: 884-888.
14. Zone JJ, Taylor TB, Kandunce DP, et al. Identification of the cutaneous basement membrane antigen in linear IgA bullous dermatosis. J Clin Invest 1990; 85: 812-820.
15. Marinkovich MP, Taylor TB, Keene DR, et al. LAD-1, the linear IgA bullous disease autoantigen, is a novel 120-kd anchoring filament protein synthesized by epidermal cells. J Invest Dermatol 1996; 106: 734-738.
16. Wojnarowska F, Whitehead P, Leigh I, et al. Identification of the target antigen in chronic bullous disease of childhood and linear IgA disease of adults. Br J Dermatol 1991; 124: 157-162.
17. Balding SD, Diaz LA, Giudice GJ. A recombinant form of the human BP180 ectodomain forms a collagen-like homotrimeric complex. Biochemistry 1997; 36: 8821-8830.
18. Tuderman Roh JY, Yee C, Lazarova Z, et al. The 120-kDa soluble ectodomain of type XVII collagen is recognized by autoantibodies in patients with pemphigoid and linear IgA dermatosis. Br J Dermatol 2000; 143: 104-111.
19. Schumann H, Baetge J, Tasanen K, et al. The shed ectodomain of collagen XVII/BP180 is targeted by autoantibodies in different blistering skin diseases. Am J Pathol 2000; 1156: 685-695.
20. Pas HH, Kloosterhuis GJ, Nijenhuis M, et al. Type XVII collagen (BP180) and LAD-1 are present as separate trimeric complexes. J Invest Dermatol 1999; 112: 58-61.
21. Pas HH, Kloosterhuis GJ, de Jong MC, et al. False-negative results in immunoblot assay of serum IgA antibodies reactive with the 180-kDa bullous pemphigoid antigen: the importance of primary incubation temperature. Br J Dermatol 2001; 145: 986-989.